Combination of Gemcitabine and Cisplatin as First-Line Therapy in Advanced Non-Small-Cell Lung Cancer
Author:
Affiliation:
1. Department of Internal Medicine, Soon Chun Hyang University College of Medicine, Seoul, Korea.
2. Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea.
Publisher
Korean Cancer Association
Subject
Cancer Research,Oncology
Link
http://www.e-crt.org/upload/pdf/crt-36-173.pdf
Reference23 articles.
1. Chemotherapy for Non-Small Cell Lung Cancer
2. Chemotherapy vs Supportive Care in Advanced Non-Small-Cell Lung Cancer
3. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Improved tumor-suppressive effect of OZ-001 combined with cisplatin mediated by mTOR/p70S6K and STAT3 inactivation in A549 human lung cancer cells;Biomedicine & Pharmacotherapy;2021-10
2. Chemotherapy-Induced Myopathy: The Dark Side of the Cachexia Sphere;Cancers;2021-07-19
3. New Strategies for Safe Cancer Therapy Using Electrospun Nanofibers: A Short Review;Mini-Reviews in Medicinal Chemistry;2020-08-20
4. Pharmacokinetic/pharmacodynamic modeling of combination-chemotherapy for lung cancer;Journal of Theoretical Biology;2018-07
5. Has aidi injection the attenuation and synergistic efficacy to gemcitabine and cisplatin in non-small cell lung cancer? A meta-analysis of 36 randomized controlled trials;Oncotarget;2016-11-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3